Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 11:12:851367.
doi: 10.3389/fonc.2022.851367. eCollection 2022.

Artificial Intelligence in Cervical Cancer Screening and Diagnosis

Affiliations
Review

Artificial Intelligence in Cervical Cancer Screening and Diagnosis

Xin Hou et al. Front Oncol. .

Abstract

Cervical cancer remains a leading cause of cancer death in women, seriously threatening their physical and mental health. It is an easily preventable cancer with early screening and diagnosis. Although technical advancements have significantly improved the early diagnosis of cervical cancer, accurate diagnosis remains difficult owing to various factors. In recent years, artificial intelligence (AI)-based medical diagnostic applications have been on the rise and have excellent applicability in the screening and diagnosis of cervical cancer. Their benefits include reduced time consumption, reduced need for professional and technical personnel, and no bias owing to subjective factors. We, thus, aimed to discuss how AI can be used in cervical cancer screening and diagnosis, particularly to improve the accuracy of early diagnosis. The application and challenges of using AI in the diagnosis and treatment of cervical cancer are also discussed.

Keywords: artificial intelligence; cervical cancer; cervical intraepithelial neoplasia (CIN); colposcopy; cytology; deep learning; early screening and diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Evolution of cervical cancer screening methods. The figure shows major milestones in the evolution of cervical cancer screening. The main screening methods for cervical cancer are HPV testing and TCT (cytology) nowadays.
Figure 2
Figure 2
Cervical cancer screening procedures are recommended for women aged 25 to 65. The American Cancer Society recommends screening starting at age 25 Colposcopy is recommended for HPV16/18 +, ASC-US and high risk HPV+ cytology with cytological results above ASC-H. Re-screening is recommended after 1 year for other abnormalities, and after 3 years for normal ones.
Figure 3
Figure 3
A example segmentation model based on Mask-RCNN architecture. Reproduced with the permission of ref. (51), copyright@IEEE, 2019. In training phase, input was pap smear slide image and nucleus ground truth mask with class label was preprocessed and then trained in Mask R-CNN. In testing phase, pap smear slide image was preprocessed. Mask RCNN was used to specify bounding box, nucleus mask, and class of each cell.
Figure 4
Figure 4
Schematic representation of application of Convolutional Neural Network in colposcopy images. Schematic depicting that a CNN pre-trained on other large-scale image datasets can be adapted to significantly increase the accuracy and shorten the training duration of a network trained on a novel dataset of colposcopy images.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer J Clin (2021) 71:209–49. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. . Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination: A Comparative Modelling Analysis in 78 Low-Income and Lower-Middle-Income Countries. Lancet (2020) 395(10224):575–90. doi: 10.1016/S0140-6736(20)30068-4 - DOI - PMC - PubMed
    1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human Papillomavirus and Cervical Cancer. Lancet (2007) 370(9590):890–907. doi: 10.1016/S0140-6736(07)61416-0 - DOI - PubMed
    1. Simms KT, Steinberg J, Caruana M, Smith MA, Lew JB, Soerjomataram I, et al. . Impact of Scaled Up Human Papillomavirus Vaccination and Cervical Screening and the Potential for Global Elimination of Cervical Cancer in 181 Countries, 2020-99: A Modelling Study. Lancet Oncol (2019) 20(3):394–407. doi: 10.1016/S1470-2045(18)30836-2 - DOI - PubMed
    1. Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. . Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update From the American Cancer Society. CA Cancer J Clin (2020) 70(5):321–46. doi: 10.3322/caac.21628 - DOI - PubMed

LinkOut - more resources